Question 1

Who are the top researchers at Cellular Engineering Technologies (United States)?

Accepted Answer

Ranked on the quality score, Alan B. Moy and Noémi Becza lead among researchers whose main affiliation is Cellular Engineering Technologies (United States).

Question 2

What are the most cited papers from Cellular Engineering Technologies (United States)?

Accepted Answer

The most cited paper from Cellular Engineering Technologies (United States) is "Standard Preanalytical Coding for Biospecimens: Review and Implementation of the Sample PREanalytical Code (SPREC)" (Sabine Michaela Lehmann et al., 2012), with 185 citations. Next come "Sublethal Lead Exposure Alters Movement Behavior in Free-Ranging Golden Eagles" (128) and "The Challenges to Advancing Induced Pluripotent Stem Cell-Dependent Cell Replacement Therapy" (59).

Question 3

Which research topics does Cellular Engineering Technologies (United States) publish most on?

Accepted Answer

By volume in 2022-now: SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Immunotherapy and Immune Responses and Pluripotent Stem Cells Research.

Question 4

Which keywords describe research at Cellular Engineering Technologies (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Immunity, Metabolism, Pattern Recognition Receptors, Innate Antiviral Responses, Toll-like Receptors and Regenerative Medicine.

Question 5

Which fields of science does Cellular Engineering Technologies (United States) work in?

Accepted Answer

In all years, 46% of research at Cellular Engineering Technologies (United States) is in Life Sciences, 30% in Health Sciences. Its largest fields are Medicine (27%), Immunology and Microbiology (20%), Biochemistry, Genetics and Molecular Biology (16%). It does 2.2× the world's share of Life Sciences.

Question 6

Is Cellular Engineering Technologies (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 32% higher than in 2018-2021.